ArticleCost effectiveness and resource allocation : C/E2023

Is Aducanumab treatment developed to prevent progression of Alzheimer's disease cost-effective in Turkey?

Vahit Yigit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.